Spark Therapeutics is within striking distance of a landmark green light from the FDA for its treatment for certain forms of blindness.
The government’s latest plans to beat cancer range from inspiring to highly questionable.
Scientists are rushing to figure out how to use the gene-editing tool to stop devastating diseases like muscular dystrophy.
This week’s most thought-provoking papers from the Physics arXiv.
Tapping the sensory cortex is the route to rediscovering feeling.
All things tend to regress to the mean.
Scientists seek the holy grail for PTSD research: targets in the brain that could respond to drugs.
Vaccine-preventable diseases cost the U.S. $9 billion in 2015, mostly because unvaccinated people got sick.
Novel treatments for neurological diseases might be possible with a flexible mesh that can prod individual brain cells.
A nonprofit is tapping sequencing technology to guide treatment for thousands of patients.